Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News | GenomeWeb

Myconostica said this week that it has launched a new version of its MycAssay Pneumocystis assay product in the European Community and Canada.

MycAssay Pneumocystis is a molecular diagnostic test for use with Cepheid's SmartCycler that detects the fungal pathogen Pneumocystis jirovecii in lower respiratory tract samples.

Pneumocystis jirovecii is typically associated with HIV/AIDS and other immunocompromised patient groups.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.